The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer
Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer
Research reveals that acquired HER2 mutations confer resistance to hormone therapy in ER-positive metastatic breast cancer
Exciting new discovery describes the mechanism of action of a new class of antibiotics
CHANGE-MS study confirms safety of GNbAC1 and reveals positive results related to neuroprotection in Multiple Sclerosis
Copley Scientific joins IPAC-RS to drive innovations in the field of OINDPs
Ralph McDade explains the importance of using ultra-sensitive immunoassays from Quanterix
AI 'scientist' finds that toothpaste ingredient may help fight drug-resistant malaria
Multiplex biochemical assays, sometimes customized, help develop the toxicity profile and selection of agrochemicals before they enter the R&D process
Prof. Patrick Gunning, Thermo Fisher Scientific, LGC and BioTek among those recognized at SelectScience's special 20th Anniversary Awards Party
SelectScience is attending SLAS 2018 in San Diego, USA, where we will host the Scientists’ Choice Awards for Drug Discovery at our special 20th Anniversary Party
A laboratory in Australia is using advanced spectrometry approaches to harness the potential of natural metabolites from marine invertebrates in drug discovery
ADVANCE trial expected to initiate patient recruitment shortly in several other EU countries, followed by the US
To be in with a chance of winning a $500/£400/450 € Amazon voucher, just tell us which new product, instrument or consumable made the most difference to your laboratory in 2017
Subsidiaries merge to become Bruker Japan K.K
